Formation Bio
The AI engine Fit Assessment
BetaFormation Bio effectively leverages machine learning and innovative technologies to expand therapeutic options and repurpose existing drugs, enhancing the drug development process.
Blurb
Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.
HQ Location
New York (United States)
Founded
2013
Employees
51 - 200
Total funding raised
$528.00M
Last Funding Event
Series D, $372.00M, June 26, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
Formation Bio is a biotechnology company that focuses on drug development to provide new treatments to patients faster by reimagining clinical trials.